Clinical Trial Update: Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction

View source ↗

Summary

This clinical trial update describes a real-world comparative effectiveness and safety study of Jardiance (empagliflozin) in Chinese patients with heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure of Reduced Ejection Fraction (HFrEF) | Status: NOT_YET_RECRUITING